Dark Forest Capital Management LP Sana Biotechnology, Inc. Transaction History

Dark Forest Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.23 - $10.44 $75,468 - $150,649	14,430 Added 112.0%	27,314 $149,000
Q1 2024 May 15, 2024	BUY	$4.2 - $11.27 $54,112 - $145,202	12,884 New	12,884 $128,000
Q1 2023 May 12, 2023	BUY	$3.11 - $4.92 $65,863 - $104,195	21,178 Added 1527.99%	22,564 $73,000
Q4 2022 Feb 13, 2023	BUY	$3.19 - $6.46 $456 - $923	143 Added 11.5%	1,386 $5,000
Q3 2022 Nov 14, 2022	SELL	$5.58 - $9.04 $1,540 - $2,495	-276 Reduced 18.17%	1,243 $7,000
Q2 2022 Aug 15, 2022	SELL	$4.12 - $9.35 $159,279 - $361,471	-38,660 Reduced 96.22%	1,519 $10,000
Q1 2022 May 13, 2022	BUY	$5.24 - $15.58 $204,506 - $608,056	39,028 Added 3390.79%	40,179 $332,000
Q4 2021 Feb 11, 2022	BUY	$15.18 - $23.15 $17,472 - $26,645	1,151 New	1,151 $18,000

172

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $613M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.